20 May 2013
Keywords: Daxas, UK, NICE, Merck & Co, Nycomed, COPD, Draft guidance
Article | 09 September 2011
New draft guidance from the UK's drug watchdog the National Institute for Health and Clinical Excellence (NICE) recommends the use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 September 2011
8 September 2011
7 September 2011
© 2013 thepharmaletter.com